Get started
Author

Satoshi Yamaori

Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
2011 · Rongrong Jiang, Satoshi Yamaori, et al. · Life Sciences · 335
Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes
2007 · Kazuhito Watanabe, Satoshi Yamaori, et al. · Life Sciences · 245
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
2011 · Satoshi Yamaori, Juri Ebisawa, et al. · Life Sciences · 227
Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
2013 · Rongrong Jiang, Satoshi Yamaori, et al. · Drug Metabolism and Pharmacokinetics · 205
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes
2010 · Satoshi Yamaori, Mika Kushihara, et al. · Biochemical Pharmacology · 171
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
2011 · Satoshi Yamaori, Yasuka Okamoto, et al. · Drug Metabolism and Disposition · 152
Comparison in the In Vitro Inhibitory Effects of Major Phytocannabinoids and Polycyclic Aromatic Hydrocarbons Contained in Marijuana Smoke on Cytochrome P450 2C9 Activity
2011 · Satoshi Yamaori, Kyoko Koeda, et al. · Drug Metabolism and Pharmacokinetics · 132
Conversion of cannabidiol to Δ9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice
2007 · Kazuhito Watanabe, Yuka Itokawa, et al. · Forensic Toxicology · 85
Involvement of Human Blood Arylesterases and Liver Microsomal Carboxylesterases in Nafamostat Hydrolysis
2006 · Satoshi Yamaori, Nobuhiro Fujiyama, et al. · Drug Metabolism and Pharmacokinetics · 71
Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers
2005 · S Yamaori, H Yamazaki, et al. · Xenobiotica · 57
Effects of cytochrome b5 on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7
2003 · Satoshi Yamaori, Hiroshi Yamazaki, et al. · Biochemical Pharmacology · 55
CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
2004 · Satoshi Yamaori, Hiroshi Yamazaki, et al. · Drug Metabolism and Pharmacokinetics · 52
Differential inhibition of human cytochrome P450 2A6 and 2B6 by major phytocannabinoids
2011 · Satoshi Yamaori, Chikako Maeda, et al. · Forensic Toxicology · 46
Δ9-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling
2008 · Shuso Takeda, Satoshi Yamaori, et al. · Toxicology · 45
Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells
2015 · Satoshi Yamaori, Yuka Kinugasa, et al. · Life Sciences · 42
PDF
Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1–expressing Primary Afferents in Mice
2016 · Satoshi Fuseya, Katsumi Yamamoto, et al. · Anesthesiology · 30
Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol
2014 · Satoshi Yamaori, Yoshimi Okushima, et al. · Chemico-Biological Interactions · 24
Structural Requirements for Potent Direct Inhibition of Human Cytochrome P450 1A1 by Cannabidiol: Role of Pentylresorcinol Moiety
2013 · Satoshi Yamaori, Yoshimi Okushima, et al. · Biological and Pharmaceutical Bulletin · 18
PDF
Δ8-Tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: Involvement of cannabinoid receptor 2 and p38 MAPK
2013 · Satoshi Yamaori, Hirosuke Ishii, et al. · Toxicology · 17
Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine
2019 · Noriaki Ikemura, Satoshi Yamaori, et al. · Chemico-Biological Interactions · 16
PDF
In Vitro Inhibition of CYP2C9-Mediated Warfarin 7-Hydroxylation by Iguratimod
2015 · Satoshi Yamaori, Ken Takami, et al. · Biological and Pharmaceutical Bulletin · 15
PDF
A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat
2018 · Satoshi Yamaori, Noriyuki Araki, et al. · Journal of Pharmacology and Experimental Therapeutics · 14
PDF
8-Hydroxycannabinol: a new metabolite of cannabinol formed by human hepatic microsomes
2006 · Kazuhito Watanabe, Satoshi Yamaori, et al. · Forensic Toxicology · 13
In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity
2020 · Hiroaki Watanabe, Satoshi Yamaori, et al. · Biological and Pharmaceutical Bulletin · 11
PDF
Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase
2007 · S. Yamaori, E. Ukena, et al. · Xenobiotica · 11
Works count: 53
Citation count: 2,202
H-index: 18
I10-index: 27
Year
Topic
Type